It's the first weight-loss drug to carry an indication for heart benefits.
he obesity drug Wegovy can now claim to lower the risk of heart attack, stroke, and other cardiovascular issues in people who are overweight or who have obesity, and also have cardiovascular disease. It's the first weight-loss drug to carry an indication for heart benefits.from Wegovy’s manufacturer, Novo Nordisk, showing that the drug lowered the risk of heart attack, stroke, or dying of heart-related issues in this population by 20% compared to people receiving placebo.
“This is an entirely new pathway to harness, of addressing obesity and its metabolic complications,” said Dr. Amit Khera, director of the Preventive Cardiology Program at the, after the results on which the approval was based were released in November. “The fact that we have a new treatment avenue for patients with cardiovascular disease is incredibly exciting, and welcome.”TIME may receive compensation for some links to products and services on this website.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
BBC's Jane Lewis speaks for first time on Brendan Rodgers 'good girl' rowDuring a BBC Sportsound radio interview following Celtic's 3-1 win against Motherwell on Sunday, Rodgers was heard saying 'good girl' following a line of questioning.
Weiterlesen »
Ozempic maker 'very optimistic' after revealing new weight loss pill twice as effective as existing jabsThe maker of the weight loss drugs Ozepmic and WeGovy has revealed a new pill for weight loss that’s twice as effective as its existing jabs.
Weiterlesen »
The two-footed enigmas: Why are so few players equally good with both feet?Genuinely two-footed players are hard to come by. We explore how players and coaches across the world try to improve their weaker one...
Weiterlesen »
Shameless Prince Harry ‘jetted home to see King Charles because he needed something to talk about in TV i...Royal expert reveals reason Meghan Markle was snubbed from Harry’s Good Morning America interview
Weiterlesen »
Someone had to say it: Scientists propose AI apocalypse kill switchesBetter visibility and performance caps would be good for regulation too
Weiterlesen »
Legal campaigners challenge UK.gov decision to redact NHS-Palantir contractFederated Data Platform agreement merits pre-action letter from Good Law Project
Weiterlesen »